FDA PMA FDA Class 3 Approved 🇺🇸 United States

Tympanostomy Tube Delivery Product With Drug

PMA: P190016 · Decision Nov 25, 2019
Classifications
1
FEI Numbers
3
Registration Numbers
3

Basic Information

Device Name
Tympanostomy Tube Delivery Product With Drug
Trade Name
Tula® System
PMA Number
P190016
Device Class
FDA Class 3
Product Code
QJA
Generic Name
Tympanostomy tube delivery product with drug
Medical Specialty
Unknown
Advisory Committee
Ear, Nose, Throat
Decision
Approved
Decision Code
APPR
Decision Date
November 25, 2019
Date Received
May 31, 2019
Expedited Review
N
Docket Number
19M-5605

Advisory Committee Statement

Approval for the Tula® System. This device is intended to create a myringotomy and insert a tympanostomy tube using the Tula Tube Delivery System in pediatric (aged 6 months and older) and adult patients indicated to receive tympanostomy tubes. The Tula System is used to deliver a tympanostomy tube under local anesthesia induced using the Tula Iontophoresis System and TYMBION, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist.TYMBION, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist, is indicated for the induction of local anesthesia of the tympanic membrane via iontophoresis using the Tula® Iontophoresis System in pediatric (aged 6 months and older) and adult patients undergoing tympanostomy tube placement using the Tula Tube Delivery SystemDrug Indications and Usage: TYMBION, a combination of an amide local anesthetic and an alpha- and beta-adrenergic agonist, is indicated for the induction of local anesthesia of the tympanic membrane via iontophoresis using the Tula® Iontophoresis System in pediatric (aged 6 months and older) and adult patients undergoing tympanostomy tube placement using the Tula Tube Delivery System.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
QJA Tympanostomy Tube Delivery Product With Drug